Treatment of Oral Warts in HIV+ Patients

Completed · Phase 2 · Has a placebo group

Conditions studied: Papillomatosis, HIV Infections

In brief

This is a study to test lozenges of interferon-alpha that are dissolved in the mouth as a treatment of oral warts in HIV-positive adults. The hypothesis of this study is that interferon-alpha will be safe and that a higher percentage of subjects given interferon-alpha will experience a complete or nearly complete remission of their oral warts compared to subjects given placebo.

Key facts

Study ID
NCT00454181
Run by
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
People needed
59
Starts
2007-02-01
Expected to finish
2009-10-01
Last updated by the study team
2011-09-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.